|
Market Closed -
Other stock markets
|
After hours 04:19:04 am | |||
| 25.33 USD | -1.71% |
|
25.39 | +0.24% |
| 04:04am | Health Care Down as Traders Eye Deal Risks - Health Care Roundup | DJ |
| 03:54am | FDA probes deaths likely related to COVID vaccines across age groups | RE |
| Capitalization | 15TCr 13TCr 12TCr 11TCr 20TCr 13,16500Cr 22TCr 1,37000Cr 53TCr 6,24000Cr 55TCr 54TCr 22,99100Cr | P/E ratio 2025 * |
13.3x | P/E ratio 2026 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise value | 19TCr 16TCr 15TCr 14TCr 26TCr 16,81500Cr 28TCr 1,74900Cr 68TCr 7,97000Cr 70TCr 69TCr 29,36400Cr | EV / Sales 2025 * |
2.99x | EV / Sales 2026 * | 2.96x |
| Free-Float |
59.04% | Yield 2025 * |
6.62% | Yield 2026 * | 6.75% |
Last Transcript: Pfizer Inc.
| 1 day | -1.47% | ||
| 1 week | +0.72% | ||
| Current month | -1.59% | ||
| 1 month | +3.85% | ||
| 3 months | +2.51% | ||
| 6 months | +5.67% | ||
| Current year | -4.52% |
| 1 week | 25.13 |  | 26.19 |
| 1 month | 23.91 | | 26.48 |
| Current year | 20.92 | | 27.69 |
| 1 year | 20.92 | | 27.69 |
| 3 years | 20.92 | | 54.93 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 63 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 60 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 24/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 67 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 61 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 63 | 01/01/2020 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 14.74% | 303 M€ | -22.24% | - |
| 9.37% | 26 M€ | +11.55% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.71% | +0.72% | -2.95% | -51.02% | 15TCr | |
| -1.54% | -6.11% | +22.23% | +172.09% | 89TCr | |
| -0.82% | -2.66% | +33.66% | +13.78% | 49TCr | |
| -0.06% | -0.94% | +26.56% | +34.34% | 39TCr | |
| -0.76% | +2.04% | +22.68% | +4.08% | 34TCr | |
| +0.10% | -1.76% | +27.58% | +20.11% | 28TCr | |
| +0.17% | +2.46% | +18.94% | +25.23% | 25TCr | |
| -2.06% | -4.10% | -6.65% | -10.93% | 25TCr | |
| +0.07% | -4.85% | -61.91% | -33.31% | 21TCr | |
| -2.30% | -7.24% | +13.05% | +12.63% | 17TCr | |
| Average | -0.71% | -1.58% | +9.32% | +18.70% | 34.15TCr | |
| Weighted average by Cap. | -0.72% | -2.22% | +15.88% | +50.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.25TCr 5.37TCr 5.04TCr 4.7TCr 8.65TCr 5,61900Cr 9.4TCr 58TCr 23TCr 2,66300Cr 23TCr 23TCr 9,81300Cr | 6.18TCr 5.31TCr 4.98TCr 4.64TCr 8.55TCr 5,55400Cr 9.29TCr 58TCr 22TCr 2,63200Cr 23TCr 23TCr 9,69900Cr |
| Net income | 1.11TCr 953.97Cr 894.98Cr 833.93Cr 1.54TCr 1LCr 1.67TCr 10TCr 4.03TCr 47TCr 4.17TCr 4.08TCr 1,74200Cr | 1.31TCr 1.12TCr 1.05TCr 980.31Cr 1.81TCr 1,17300Cr 1.96TCr 12TCr 4.74TCr 56TCr 4.9TCr 4.79TCr 2,04800Cr |
| Net Debt | 4.06TCr 3.49TCr 3.27TCr 3.05TCr 5.62TCr 3,64900Cr 6.11TCr 38TCr 15TCr 1,73000Cr 15TCr 15TCr 6,37300Cr | 3.62TCr 3.11TCr 2.92TCr 2.72TCr 5.01TCr 3,25300Cr 5.44TCr 34TCr 13TCr 1,54200Cr 14TCr 13TCr 5,68000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/25/10 | 25.33 $ | -1.71% | 4,34,15,399 |
| 08/25/08 | 25.77 $ | -1.00% | 4,52,09,347 |
| 05/25/05 | 26.03 $ | +1.28% | 4,74,43,701 |
| 04/25/04 | 25.70 $ | +0.51% | 3,54,53,966 |
| 03/25/03 | 25.57 $ | +1.67% | 5,61,21,174 |
Delayed Quote Nyse, December 10, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition